The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Open accessAbstract
Recently, we demonstrated a significant increase of an oxidized nucleoside derived from RNA, 8-hydroxyguanosine (8OHG), and an oxidized amino acid, nitrotyrosine in vulnerable neurons of patients with Alzheimer disease (AD). To determine whether oxidative damage is an early- or end-stage event in the process of neurodegeneration in AD, we investigated the relationship between neuronal 8OHG and nitrotyrosine and histological and clinical variables, i.e. amyloid-beta (A beta) plaques and neurofibrillary tangles (NFT), as well as duration of dementia and apolipoprotein E (ApoE) genotype. Our findings show that oxidative damage is quantitatively greatest early in the disease and reduces with disease progression. Surprisingly, we found that increases in A beta deposition are associated with decreased oxidative damage. These relationships are more significant in ApoE epsilon4 carriers. Moreover, neurons with NFT show a 40%-56% decrease in relative 8OHG levels compared with neurons free of NFT. Our observations indicate that increased oxidative damage is an early event in AD that decreases with disease progression and lesion formation. These findings suggest that AD is associated with compensatory changes that reduce damage from reactive oxygen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Past and recent studies have demonstrated that oxidative damage is not only an early event in the pathogenesis of AD, occurring before the onset of clinical symptoms but also a factor contributing to the disease progression [17,18,19,20,21].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [19]
In the citing paper
“In the brains of individuals with AD and preclinical AD (i.e., evidence of Aβ and tau deposition in the brain without any clinical manifestation of the disease), as well as patients with MCI (a mild clinical impairment with no proof of underlying pathology with biomarkers), many oxidative damage products are measured, and numerous investigations have pointed to OS as a key and early player in the”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [19]
In the citing paper
“In the AD brain, mitochondria can be sources of ROS and also the target of OS, especially mitochondrial DNA (mtDNA) is susceptible to oxidative damage [19,53,63].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [19]
In the citing paper
“Oxidative damage to RNA in EC, hippocampus, subiculum, and temporal neocortex of subjects with AD has been described. The levels of 8-OHdG increase early before pathological changes occur, and this can explain that the selective vulnerability of neurons in the EC during AD may be related to the vulnerability of these particular neurons to oxidative damage [19].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Theory and Practice of Histological Techniques
Bancroft, J. D., & Gamble, M. (1990) · Cited by 6,948
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Self-citationReiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Research works printed but not linked: 2
- Smith, 1998, ApoE: Isoform specific antioxidant activity [abstract], Neurobiol Aging, 19, S222
- Nunomura, 2000, Increasing amyloid ß 42 deposition is associated with decreasing neuronal RNA oxidation in Down's syndrome and familial Alzheimer's disease [abstract], Brain pathol, 10, 783
Cited by
Sorted by citations
Items 501–600 of 1,005
Impact of caffeic acid on aluminium chloride-induced dementia in rats
Khan, K. A., Kumar, N., Nayak, P. G., Nampoothiri, M., Shenoy, R. R., Nandakumar, K., Rao, C. M., & Mudgal, J. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12126 · Cited by 93
Brain Erythropoietin Receptor Expression in Alzheimer Disease and Mild Cognitive Impairment
Assaraf, M. I., Diaz, Z., Liberman, A., Miller, W. H., Arvanitakis, Z., Li, Y., Bennett, D. A., & Schipper, H. M. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3180517b28 · Cited by 93
Blood markers of oxidative stress in A lzheimer's disease
Skoumalová, A., & Hort, J. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01585.x · Cited by 93
Oxidatively modified RNA in mild cognitive impairment
Lovell, M. A., & Markesbery, W. R. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.030 · Cited by 93
Quiroz‐Baez, R., Rojas, E., & Arias, C. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.06.012 · Cited by 93
Nutraceuticals against Neurodegeneration: A Mechanistic Insight
Dadhania, V. P., Trivedi, P. P., Vikram, A., & Tripathi, D. N. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160104142223 · Cited by 93
Duarte, A. I., Candeias, E., Alves, I. N., Mena, D., da Silva, D. F., Machado, N. J., Campos, E. J., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051746 · Cited by 94
A Review on Lactoferrin and Central Nervous System Diseases
Li, Y.-Q., & Guo, C. (2021) · Cells · doi:10.3390/cells10071810 · Cited by 92
Thal, D. R., & Tomé, S. O. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.10.006 · Cited by 92
Atwood, C., Meethal, S. V., Liu, T., Wilson, A. C., Gallego, M. J., Smith, M. A., & Bowen, R. L. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.93 · Cited by 92
Self-citationGozal, Y. M., Duong, D. M., Gearing, M., Cheng, D., Hanfelt, J., Funderburk, C. D., Peng, J., Lah, J. J., & Levey, A. I. (2009) · Journal of Proteome Research · doi:10.1021/pr900474t · Cited by 92
Denzer, I., Münch, G. W., & Friedland, K. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.019 · Cited by 91
The NADPH Oxidase Family and Its Inhibitors
Chocry, M., & Leloup, L. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7915 · Cited by 91
Mediterranean diet and cognitive function: From methodology to mechanisms of action
Siervo, M., Shannon, O. M., Llewellyn, D. J., Stephan, B. C. M., & Fontana, L. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.09.018 · Cited by 91
Yao, Y., Chinnici, C. M., Tang, H., Trojanowski, J. Q., Lee, V. M. ‐., & Praticò, D. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-21 · Cited by 91
Wen, X., Huang, A., Hu, J., Zhong, Z., Liu, Y., Li, Z., Pan, X., & Liu, Z. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.034 · Cited by 91
Aliev, G., Seyidova, D., Lamb, B. T., Obrenovich, M. E., Siedlak, S. L., Vinters, H. V., Friedland, R. P., Siedlak, S. L., Vinters, H. V., Friedland, R. P., et al. (2003) · Neurological Research · doi:10.1179/016164103101201977 · Cited by 91
Self-citationAliev, G., Seyidova, D., Neal, M. L., Shi, J., Lamb, B. T., Siedlak, S. L., Vinters, H. V., Head, E., Perry, G. L., LaManna, J. C., et al. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04798.x · Cited by 91
Self-citationKomaki, H., Faraji, N., Komaki, A., Shahidi, ., Etaee, F., Raoufi, S., & Mirzaei, F. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.01.025 · Cited by 91
Alzheimer's Disease: Cerebrovascular Dysfunction, Oxidative stress, and Advanced Clinical Therapies
Marlatt, M. W., Lucassen, P. J., Perry, G. L., Smith, M. A., & Zhu, X. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15206 · Cited by 90
Self-citationOxidative stress promotes $tau; dephosphorylation in neuronal cells: the roles of cdk5 and PP1
Zambrano, C. A., Egaña, J. T., Núñez, M. T., Maccioni, R. B., & González-Billault, C. E. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.03.007 · Cited by 90
Regulation of claudins in blood-tissue barriers under physiological and pathological states
Gonçalves, A., Ambrósio, A. F., & Fernandes, R. (2013) · Tissue Barriers · doi:10.4161/tisb.24782 · Cited by 90
Chhimpa, N., Singh, N., Puri, N., & Kayath, H. P. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220514 · Cited by 89
Synaptic dysfunction and oxidative stress in Alzheimer's disease: Emerging mechanisms
Forero, D. A., Casadesús, G., Perry, G. L., & Arboleda, H. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00439.x · Cited by 89
Self-citationThomas, P., Wang, Y., Zhong, J., Kosaraju, S. L., O’Callaghan, N. J., Zhou, X., & Fenech, M. F. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.10.016 · Cited by 89
The role of glycogen synthase kinase 3 in the early stages of Alzheimers’ disease
Hernández, F., & Ávila, J. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.10.026 · Cited by 88
Atamna, H., Frey, W. H., & Ko, N. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.05.003 · Cited by 88
Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?
Reddy, P. H. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.003 · Cited by 88
Puig, B., Gómez‐Isla, T., Ribé, E. M., Cuadrado‐Tejedor, M., Torrejón-Escribano, B., Dalfó, E., & Ferrer, I. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00569.x · Cited by 88
Lovell, M. A. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0992 · Cited by 87
D’Souza, Y., Elharram, A., Soon-Shiong, R., Andrew, R. D., & Bennett, B. M. (2015) · Molecular Brain · doi:10.1186/s13041-015-0117-y · Cited by 87
Alzheimer’s disease: as it was in the beginning
Kozlov, S. O., Afonin, A. М., Evsyukov, I., & Бондаренко, А. Б. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0006 · Cited by 87
Yamaguchi, H., Kajitani, K., Dan, Y., Furuichi, M., Ohno, M., Sakumi, K., Kang, D., & Nakabeppu, Y. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401788 · Cited by 87
Neuropathological analysis in spinal muscular atrophy type II
Araki, S., Hayashi, M., Tamagawa, K., Saito, M., Kato, S., Komori, T., Sakakihara, Y., Mizutani, T., & Oda, M. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0743-9 · Cited by 87
A review of genome mutation and Alzheimer's disease
Thomas, P., & Fenech, M. F. (2006) · Mutagenesis · doi:10.1093/mutage/gel055 · Cited by 88
Ghumatkar, P. J., Patil, S. P., Jain, P. D., Tambe, R., & Sathaye, S. S. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.06.005 · Cited by 87
Mitochondrial Abnormalities in Alzheimer’s Disease
Silva, D. F., Selfridge, J. E., Lu, J., E, L., Cardoso, S. M., & Swerdlow, R. H. (2012) · Advances in Pharmacology · doi:10.1016/b978-0-12-394816-8.00003-9 · Cited by 86
Giulia, N., Sestito, S., Digiacomo, M., & Rapposelli, S. (2017) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026617666170607114232 · Cited by 86
Polyunsaturated Fatty Acid Deuteration against Neurodegeneration
Shchepinov, M. S. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.01.010 · Cited by 86
Quantitative MR imaging R2 relaxometry in elderly participants reporting memory loss.
House, M. J., Pierre, T. G. S., Foster, J. K., Martins, R. N., & Clarnette, R. (2006) · PubMed Central · Cited by 86
Gunn, A. P., Wong, B. X. W., Johanssen, T., Griffith, J. C., Masters, C. L., Bush, A. I., Barnham, K. J., Duce, J. A., & Cherny, R. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.655183 · Cited by 86
Mitochondria and Antioxidant Targeted Therapeutic Strategies for Alzheimer's Disease
Dumont, M., Lin, M. T. S., & Beal, M. F. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100507 · Cited by 85
Bono, S., Feligioni, M., & Corbo, M. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00479-8 · Cited by 86
Gu, F., Zhu, M., Shi, J., Hu, Y., & Zhao, Z. Y. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.050 · Cited by 85
A possible link between astrocyte activation and tau nitration in Alzheimer's disease
Reyes, J. F., Reynolds, M. R., Horowitz, P. M., Fu, Y., Guillozet-Bongaarts, A. L., Berry, R., & Binder, L. I. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.04.005 · Cited by 85
The Gonadotropin Connection in Alzheimer's Disease
Meethal, S. V., Smith, M. A., Bowen, R. L., & Atwood, C. (2005) · Endocrine · doi:10.1385/endo:26:3:317 · Cited by 85
Self-citationCheng, D., Yang, S., Zhao, X., & Wang, G. (2022) · Drug Design, Development and Therapy · doi:10.2147/dddt.s348055 · Cited by 84
Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-β peptide
Hayashi, T., Shishido, N., Nakayama, K., Nunomura, A., Smith, M. A., Perry, G. L., & Nakamura, M. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.08.013 · Cited by 84
Self-citationAPOE and neuroenergetics: an emerging paradigm in Alzheimer's disease
Wolf, A. B., Caselli, R. J., Reiman, E. M., & Valla, J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.011 · Cited by 84
Aliev, G., Smith, M. A., de la Torre, J. C., & Perry, G. L. (2004) · Mitochondrion · doi:10.1016/j.mito.2004.07.018 · Cited by 84
Self-citationFatma, N., Kubo, E., Sen, M., Agarwal, N. A., Thoreson, W. B., Camras, C. B., & Singh, D. P. (2008) · Brain Research · doi:10.1016/j.brainres.2008.07.076 · Cited by 84
JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1
Tamagno, E., Guglielmotto, M., Giliberto, L., Vitali, A., Borghi, R., Autelli, R., Danni, O., & Tabaton, M. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.015 · Cited by 84
Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients
Ghanbari, H. A., Ghanbari, K., Harris, P. L. R., Jones, P. K., Kubat, Z., Castellani, R. J., Wolozin, B. L., Smith, M. A., & Perry, G. L. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00083.x · Cited by 84
Self-citationNeuronal RNA oxidation is a prominent feature of dementia with Lewy bodies
Nunomura, A., Chiba, S., Kosaka, K., Takeda, A., Castellani, R. J., Smith, M. A., & Perry, G. L. (2002) · Neuroreport · doi:10.1097/00001756-200211150-00009 · Cited by 84
Self-citationThe protective role of plant biophenols in mechanisms of Alzheimer's disease
Omar, S. H., Scott, C., Hamlin, A. S., & Obied, H. K. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.02.016 · Cited by 84
Talebi, M., İlgün, S., Ebrahimi, V., Talebi, M., Farkhondeh, T., Ebrahimi, H., & Samarghandian, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111088 · Cited by 83
L-arginine and Alzheimer's disease.
Yi, J., Horky, L. L., Friedlich, A. L., Shi, Y., Rogers, J. T., & Huang, X. (2009) · PubMed · Cited by 85
8-OHdG in Cerebrospinal Fluid as a Marker of Oxidative Stress in Various Neurodegenerative Diseases
Gmitterová, K., Heinemann, U., Gawinecka, J., Varges, D., Ciesielczyk, B., Valkovič, P., Benetin, J., & Zerr, I. (2009) · Neurodegenerative Diseases · doi:10.1159/000237221 · Cited by 83
The effect of formalin fixation on the levels of brain transition metals in archived samples
Schrag, M., Dickson, A., Jiffry, A., Kirsch, D., Vinters, H. V., & Kirsch, W. M. (2010) · BioMetals · doi:10.1007/s10534-010-9359-4 · Cited by 83
Calingasan, N. Y., Chen, J., Kiaei, M., & Beal, M. F. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.01.012 · Cited by 83
Moreira, P. I. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111127 · Cited by 83
Copper reduction by copper binding proteins and its relation to neurodegenerative diseases
Opazo, C., Barría, M. I., Ruiz, F. H., & Inestrosa, N. C. (2003) · BioMetals · doi:10.1023/a:1020795422185 · Cited by 83
Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy
Cente, M., Filipcik, P., Pevalova, M., & Novak, M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04986.x · Cited by 82
Merlo, S., Spampinato, S. F., & Sortino, M. A. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13050 · Cited by 82
Alzheimer's Disease and Amyloid: Culprit or Coincidence?
Skaper, S. D. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00011-9 · Cited by 82
Henderson, V. W., & Brinton, R. D. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)82003-5 · Cited by 82
Free Copper Distinguishes Mild Cognitive Impairment Subjects from Healthy Elderly Individuals
Squitti, R., Ghidoni, R., Scrascia, F., Benussi, L., Panetta, V., Pasqualetti, P., Moffa, F., Bernardini, S., Ventriglia, M., Binetti, G. G., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101098 · Cited by 82
Intraneuronal amyloid β accumulation and oxidative damage to nucleic acids in Alzheimer disease
Nunomura, A., Tamaoki, T., Tanaka, K., Motohashi, N., Nakamura, M., Hayashi, T., Yamaguchi, H., Shimohama, S., Lee, H., Zhu, X., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.012 · Cited by 82
Self-citationLongitudinal CSF isoprostane and MRI atrophy in the progression to AD
de Leon, M. J., Mosconi, L., Li, J., Santi, S. D., Yao, Y., Tsui, W.-H., Pirraglia, E., Rich, K. E., Javier, E., Bryś, M., et al. (2007) · Journal of Neurology · doi:10.1007/s00415-007-0610-z · Cited by 82
SIRT3 activator Honokiol attenuates β-Amyloid by modulating amyloidogenic pathway
Ramesh, S., Govindarajulu, M., Lynd, T. O., Briggs, G. H., Adamek, D., Jones, E., Heiner, J., Majrashi, M., Moore, T., Amin, R., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190350 · Cited by 82
Shah, S. A., Yoon, G. H., Ahmad, A., Ullah, F., Amin, F. U., & Kim, M. O. (2015) · Nanoscale · doi:10.1039/c5nr03598h · Cited by 81
Oxidative damage in the olfactory system in Alzheimer's disease
Perry, G. L., Castellani, R. J., Smith, M. A., Harris, P. L. R., Kubat, Z., Ghanbari, K., Jones, P. K., Cordone, G., Tabaton, M., Wolozin, B. L., et al. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0761-7 · Cited by 81
Self-citationPromotion of Amyloid β Protein Misfolding and Fibrillogenesis by a Lipid Oxidation Product
Liu, L., Komatsu, H., Murray, I. V. J., & Axelsen, P. H. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.01.057 · Cited by 81
Oxidative Damage to Nucleic Acids in Severe Emphysema
Deslée, G., Woods, J. C., Moore, C. H., Conradi, S. H., Gierada, D. S., Atkinson, J. J., Battaile, J. T., Liu, L., Patterson, G. A., Adair-Kirk, T. L., et al. (2008) · CHEST Journal · doi:10.1378/chest.08-2257 · Cited by 81
The state versus amyloid-β: the trial of the most wanted criminal in Alzheimer disease
Rottkamp, C. A., Atwood, C., Joseph, J. A., Nunomura, A., Perry, G. L., & Smith, M. A. (2002) · Peptides · doi:10.1016/s0196-9781(02)00069-4 · Cited by 81
Self-citationOxidative stress in Alzheimer's disease: Primary villain or physiological by-product?
Sutherland, G. T., Chami, B., Youssef, P., & Witting, P. K. (2013) · Redox Report · doi:10.1179/1351000213y.0000000052 · Cited by 80
Obrenovich, M. E., Smith, M. A., Siedlak, S. L., Chen, S. G., de la Torre, J. C., Perry, G. L., & Aliev, G. (2006) · Neurotoxicity Research · doi:10.1007/bf03033333 · Cited by 80
Self-citationViolet, M., Chauderlier, A., Delattre, L., Tardivel, M., Chouala, M. S., Sultan, A., Marciniak, E., Humez, S., Binder, L. I., Kayed, R., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.09.003 · Cited by 80
E3 Ubiquitin Ligases Neurobiological Mechanisms: Development to Degeneration
Upadhyay, A., Joshi, V., Amanullah, A., Mishra, R., Arora, N., Prasad, A., & Mishra, A. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00151 · Cited by 80
Intracellular A-Beta Amyloid, A Sign for Worse Things to Come?
Echeverría, V., & Cuello, A. C. (2002) · Molecular Neurobiology · doi:10.1385/mn:26:2-3:299 · Cited by 81
Calderón‐Garcidueñas, L., Cross, J. V., Franco-Lira, M., Aragón-Flores, M., Kavanaugh, M., Torres‐Jardón, R., Chao, C., Thompson, C., Chang, J., Hongtu Zhu, B., et al. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00183 · Cited by 79
Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease
Siedlak, S. L., Casadesús, G., Webber, K. M., Pappolla, M. A., Atwood, C., Smith, M. A., & Perry, G. L. (2009) · Free Radical Research · doi:10.1080/10715760802644694 · Cited by 79
Self-citationXicota, L., Rodríguez-Morató, J., Dierssen, M., & de la Torre, R. (2015) · Current Drug Targets · doi:10.2174/1389450116666150825113655 · Cited by 79
Panax ginseng components and the pathogenesis of Alzheimer's disease (Review)
Razgonova, M. P., Veselov, V. V., Zakharenko, A. M., Golokhvast, K. S., Nosyrev, A. E., Cravotto, G., Tsatsakis, A. M., & Spandidos, D. A. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.9972 · Cited by 81
Tang, L., Wang, R., & Tang, X.-C. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.06.026 · Cited by 79
Dendritic changes in visual pathways in glaucoma and other neurodegenerative conditions
Liu, M., Duggan, J., Salt, T. E., & Cordeiro, M. F. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.01.014 · Cited by 78
Olajide, O. J., Suvanto, M. E., & Chapman, C. A. (2021) · Biology Open · doi:10.1242/bio.056796 · Cited by 77
Kriegenburg, F., Poulsen, E. G., Koch, A., Krüger, E., & Hartmann‐Petersen, R. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3590 · Cited by 77
Lee, S. H., Kim, I., & Chung, B. C. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.11.021 · Cited by 77
Franco, S., Blasco, M. A., Siedlak, S. L., Harris, P. L. R., Moreira, P. I., Perry, G. L., & Smith, M. A. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.03.001 · Cited by 77
Self-citationTRPC Channels and their Implications for Neurological Diseases
Selvaraj, S., Sun, Y., & Singh, B. B. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710790966650 · Cited by 77
Bergen, J. M. G. V., Li, X., Quevenco, F. C., Gietl, A. F., Treyer, V., Meyer, R., Buck, A., Kaufmann, P. A., Nitsch, R. M., van Zijl, P. C. M., et al. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.03.021 · Cited by 77
Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer’s disease
Völkel, W., Sicilia, T., Pähler, A., Gsell, W., Tatschner, T., Jellinger, K., Leblhuber, F., Riederer, P., Lutz, W. K., & Götz, M. E. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.12.003 · Cited by 76
Terry, D. M., & Devine, S. E. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01244 · Cited by 76
[The two faces of reactive oxygen species].
Zabłocka, A., & Janusz, M. (2008) · PubMed · Cited by 76
Maidana, M., Carlis, V., Galhardi, F. G., Yunes, J. S., Geracitano, L. A., Monserrat, J. M., & Barros, D. M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.12.001 · Cited by 76
Toxic Role of K+Channel Oxidation in Mammalian Brain
Cotella, D., Hernández-Enríquez, B., Wu, X., Li, R., Pan, Z., Leveille, J., Link, C. D., Oddo, S., & Sesti, F. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6153-11.2012 · Cited by 76
Oxidative stress up-regulates presenilin 1 in lipid rafts in neuronal cells
Oda, A., Tamaoka, A., & Araki, W. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22271 · Cited by 76
The Bewildering Effect of AMPK Activators in Alzheimer’s Disease: Review of the Current Evidence
Assefa, B. T., Tafere, G. G., Wondafrash, D. Z., & Gidey, M. T. (2020) · BioMed Research International · doi:10.1155/2020/9895121 · Cited by 76
Sildenafil for the Treatment of Alzheimer’s Disease: A Systematic Review
Sanders, O. D. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200166 · Cited by 76
Metadata
- Authors
- Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., Chiba, S., Atwood, C. S., Petersen, R. B., & Smith, M. A.
- Affiliations
- Asahikawa Medical University (JP)
- Case Western Reserve University (US)
- Takeda (Japan) (JP)
- Sensei Biotherapeutics (United States) (US)
- Kyoto University (JP)
- Corresponding author
- Nunomura, Akihiko
- ORCID
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-08
- Volume
- 60
- Issue
- 8
- Pages
- 759-767
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- OpenAlex
- W1542215809
- Cited by
- 1,885
- References
- 59
- Citations by year
- 2026: 46 · 2025: 31 · 2024: 52 · 2023: 61 · 2022: 80 · 2021: 98 · 2020: 86 · 2019: 82 · 2018: 69 · 2017: 73 · 2016: 70 · 2015: 83 · 2014: 86 · 2013: 86 · 2012: 104
- FWCI
- 33.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuropathology & Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Asahikawa Medical University Collection and Research (Asahikawa Medical University) (submittedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- Alzheimer's Association
- National Institutes of Health (5r01ag009287-08, AG09287)
- Japan Society for the Promotion of Science (12670918)
- National Institute on Aging (AG-14249, R01AG014249, AG 09287)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, oxidative damage, 8-hydroxyguanosine, nitrotyrosine, amyloid plaques, neurofibrillary tangles, APOE ε4, disease progression, neurodegeneration, reactive oxygen species, RNA oxidation
- MeSH terms
- Aged, Alzheimer Disease, Apolipoproteins E, Brain, Female, Genotype, Guanosine, Heterozygote, Humans, Male, Middle Aged, Neurons, Tyrosine, Amyloid beta-Peptides, Neurofibrillary Tangles, Oxidative Stress, Disease Progression, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
